baber/WOPTO huggingface dataset:
Patent NZ-502886-A (NZ)
Title: A lock apparatus includes two spaced apart lock assemblies
Inventor: IRWIN STEPHEN
IPC: E05C9/04
Filed: 2000-02-16
Abstract: A lock apparatus for a door or window has at least two space d apart lock assemblies 11 & 12 operatively connected to each other.  Each lock assembly 11 or 12 has a housing, a hook bolt 17 or 18 rotatably attached relative to the housing for movement between an extended locked position and a retracted unlocked position.  An elongate slide member 27 or 28 has one end operatively attached to bolt 17 or 18 and another end extending from the housing.  Slide member 27 or 28 is reciprocally moveable to cause hook bolt 17 or 18 to move between its locked and unlocked positions.  A rigid link member 30 interconnects each slide member such that reciprocal movement of one slide member causes reciprocal movement of the other slide member.  A handle 41 is attached to one of the slide members and can be manipulated to cause the slide members to reciprocate.
Patent NZ-510743-A (NZ)
Title: mGluR5 antagonists for the treatment of pain and anxiety
Inventor: ALLGEIER HANS
IPC: A61P25/18
Filed: 1999-09-30
Abstract: Selective metabotropic glutamate receptor (mGluR5) antagonists such as substituted pyridine derivatives are used in the manufacture of a medicament for the treatment of anxiety or for transdermal application to treat pain.
Patent NZ-516400-A (NZ)
Title: Stable factor VIII compositions
Inventor: MIKAELSSON MARIANNE
IPC: A61P7/04
Filed: 2000-07-07
Abstract: Described is a pharmaceutical composition comprising Factor VIII and the divalent metal ions Zn2+ and Cu2+, optionally in the presence of Ca2+ ions and/or Mn2+ ions, wherein the Factor VIII is stable without the addition of albumin. Described also, but not claimed, is a method for the production of recombinant Factor VIII from mammalian cells carrying the gene therefor, comprising culturing said mammalian cells in medium free of plasma-derived protein and supplemented with divalent metal ions, including Cu2+ and Zn2+, and optionally in the presence of Ca2+ and Mn2+ ions.
Patent NZ-519081-A (NZ)
Title: Process for enhancing canine and feline reproductive performance by feeding omega-6 and omega-3 fatty acids.
Inventor: KELLEY RUSSELL L
IPC: A23K1/18
Filed: 2000-11-22
Abstract: A process for enhancing reproductive performance in a companion animal comprising feeding said animal a diet including omega-6 and omega-3 fatty acids, wherein the ratio of omega-6 to omega-3 fatty acids is from about 3.5:1 to about 12.5:1.
Patent NZ-520711-A (NZ)
Title: N-hydroxy-5-ethoxymethyloxy-2(S)-methyl-4(S)-(4- phenoxybenzoyl)aminopentanamide useful for treating osteoarthritis
Inventor: MAEDA YOSHIZOU
IPC: A61K31/166
Filed: 2001-02-09
Abstract: A treatment and/or preventives agent for degenerative arthritis (osteoarthritis) is disclosed, which contains as the active ingredient N-hydroxy-5-ethoxymethyloxy-2(S)- methyl-4(S)-(4-phenoxybenzoyl)aminopentanamide, and which has an activity of inhibiting matrix metalloproteinase, or nontoxic salts of the same.
Patent NZ-523596-A (NZ)
Title: Electronic application assessment to determine approval or rejection of the application e.g. for loans
Inventor: MA SHERMAN CHING
IPC: G06Q40/02
Filed: 2000-04-03
Abstract: An apparatus for receiving and assessing an application made by an applicant includes computing means (23) configured or programmed to receive application information and to assess the application. The apparatus includes or can access, application approval criteria (12) of a plurality of application recipients (21), and the computing means (23) is configured or programmed to assess the application according to the approval criteria of the each of the plurality of application recipients (21). The apparatus can thereby form a respective separate assessment comprising approval or rejection for each of the plurality of recipients (21).
Patent NZ-525051-A (NZ)
Title: Interchangeable loudspeaker baffle assembly
Inventor: STERNS FRANK
IPC: H04R1/02
Filed: 2001-08-31
Abstract: A system of interchangeable loudspeaker baffle assemblies is disclosed. The present invention is a system of baffle assemblies that enable a listener or installer to conveniently change in-wall, or automobile, loudspeaker configurations. More particularly, the present invention allows loudspeaker assemblies of varying configurations to be detachably affixed to the frame 60 attached to a wall or to the interior of a vehicle, a plurality of differently configured loudspeaker assemblies, and a means for easily attaching and detaching the loudspeaker assemblies form the frame 60. The means, for example, including a combination of snap-in clips 80 and locking feet 90.
Patent NZ-526468-A (NZ)
Title: Pyrazole compounds useful as protein kinase inhibitors
Inventor: BEBBINGTON DAVID
IPC: A61K31/513
Filed: 2001-12-19
Abstract: This invention describes novel pyrazole compounds of formula (IIa): wherein R1 is T-Ring D, wherein Ring D is 5- 7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; Rx and Ry are taken together with their intervening atoms to form a fused, unsaturated or partially unsaturated, 5-7 membered ring having 0-3 heteroatoms; and R2 and R2' are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
Patent NZ-527111-A (NZ)
Title: New use of iloperidone
Inventor: KALKMAN HANS O
IPC: A61K31/445
Filed: 2002-02-04
Abstract: The use of iloperidone (1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]ethanone) or a pharmaceutically acceptable acid addition salt thereof, for the manufacture of a pharmaceutical composition for the treatment of affective and attention/behavioural disorders.
Patent NZ-527520-A (NZ)
Title: Insulated Beverage or food container
Inventor: LAZAR JOHN MACKAY
IPC: B29C48/08
Filed: 2002-06-11
Abstract: An insulating beverage cup or sleeve is produced with a foam layer disposed on an inner surface of a food or beverage paper stock. A polyethylene film layer is arranged in a position between a paper stock layer and an inside surface of the beverage container. The foam layer decreases the energy transfer between the beverage and the user's hands allowing the user to hold onto the cup for an extended period of time without causing user discomfort or pain, e.g. greatly extends the hold time of the paper cup. The exterior surface of the beverage cup remains highly printable and predisposed to high quality graphics both before and after cup manufacture.
Patent NZ-530043-A (NZ)
Title: Hetero-bicyclic CRF antagonists
Inventor: DI FABIO ROMANO
IPC: A61P37/08
Filed: 2002-07-15
Abstract: Disclosed are compounds of formula (I), wherein; R is optionally substituted aryl or heteroaryl, R1 is H, alkyl, alkenyl, alkynyl, halo-alkyl, halo-alkoxy, halogen, NR6R7 or cyano, R2 and R3 together form a pyrazolyl radical, and R4 is H, alkyl, halogen or halo-alkyl. The compounds are used for the manufacture of medicaments for the treatment of conditions mediated by CRF (corticotrophin-releasing factor).
Patent NZ-531837-A (NZ)
Title: Security lock supporting master keying
Inventor: NUGENT WALTER JOSEPH
IPC: E05B27/06
Filed: 2002-10-18
Abstract: A lock of the type in which a latch means is able to be actuated if elongated members are able to pass through associated slots (54) in latch elements. There are two sets of latch elements (50) in two keyways (48, 49) such that, when the slots in opposed pairs of elements are aligned, the actuating members can pass through. One set of latch elements (54) are positioned by a setter or biscuit (56) and the other set are positioned by a key (58) that corresponds to the shape of the setter to align the slots of corresponding elements in each set. This type of lock is improved by providing at least one latch element in one set (i.e., in one keyway 48 or 49), with a wider slot (54) to enable master keying. The master key is set to correspond to the highest or lowest position in the wide slot.
Patent NZ-537740-A (NZ)
Title: Arylamine substituted bicyclic heteroaromatic compounds as P38 kinase inhibitors
Inventor: BROOKINGS DANIEL CHRISTOPHER
IPC: A61P25/16
Filed: 2003-06-20
Abstract: Disclosed are compounds of the formula (I), wherein The dashed line joining A and C(Ra) is present and represents a bond, and A is a ûC(Rb)= group, or the dashed line is absent and A is a ûC(Rb)(Rc)- group; R is H or a straight or branched C1-6- alkyl group; X is an ûO- or ûS- atom; Y is a N or substituted C atom or a ûCH= group; N is 0 or 1; Alk1 is an optionally substituted aliphatic or heteroaliphatic chain; L1 is a covalent bond or a linker atom or group; Cy1 is a H or an optionally a substituted cycloaliphatic, poly cycloaliphatic, hetereocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic group; Ar is an optionally substituted aromatic or heteroaromatic group; And the salts, solvates, hydrates and N-oxides thereof. Further disclosed are pharmaceutical compositions comprising a compound of formula (I); and the use of one of the compounds of the invention for the manufacture of a medicament for the treatment of rheumatoid arthritis.
Patent NZ-539386-A (NZ)
Title: N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
Inventor: WARSHAKOON NAMAL CHITHRANGA
IPC: C07D401/06
Filed: 2003-11-07
Abstract: Disclosed is a compound of formula (I) wherein: a) each R-1 is independently chosen from hydrogen, halo, cyano, hydroxyl, carboxy, keto, thioketo, amino, acylamino, acyl, amido, phenyl, aryloxy, alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, alkoxy, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl; b) each R2 is independently chosen from hydrogen, halo, cyano, hydroxyl, carboxy, keto, thioketo, amino, acylamino, acyl, amido, phenyl, aryloxy, alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, alkoxy, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl; c) R3 and R4 are each independently chosen from hydrogen, alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, alkylheteroalkyl, alkylaryl, alkylheteroaryl, alkylcycloalkyl and alkylheterocycloalkyl; or R3 and R4, together with the nitrogen atom to which they are bonded, join to form heteroaryl, or heterocycloalkyl moieties, optionally substituted with one or more hydrogen, halo, cyano, hydroxyl, carboxy, keto, thioketo, amino, acylamino, acyl, amido, phenyl, aryloxy, alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, alkoxy, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, spirocycloalkyl and combinations thereof; d) R5 and R6 are each independently chosen from hydrogen, halo, cyano, hydroxyl, carboxy, keto, thioketo, amino, acylamino, acyl, amido, phenyl, aryloxy, alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, alkoxy, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl; or a pharmaceutically-acceptable salt thereof. Also disclosed is the use of the above compound for the manufacture of a pharmaceutical composition for treating a bacterial infection in a patient in need thereof.
Patent NZ-543993-A (NZ)
Title: Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
Inventor: SMITH ROGER
IPC: C07D263/58
Filed: 2004-05-06
Abstract: Disclosed are compounds of formulae (I), (Ia), (Ib) and (VIII), wherein the substituents are as defined in the specification; processes for their preparation and their utility as agents for treating or preventing obesity and related diseases such as dyslipidemia, cholesterol gallstones, gallbladder disease, gout, cancer, menstrual abnormalities, infertility, polycystic ovaries, osteoarthritis, sleep apnea, hypertriglyceridemia, Syndrome X, type 2 diabetes, atherosclerotic diseases, hyperlipidemia, hypercholesteremia, low HDL levels, hypertension, cardiovascular disease, coronary heart disease, coronary artery disease, cerebrovascular disease, stroke, and peripheral vessel disease.
Patent NZ-545954-A (NZ)
Title: DNA vaccine compositions and methods of use
Inventor: NARAYAN OPENDRA
IPC: A01N63/00
Filed: 2004-09-16
Abstract: Provided is a DNA immunogenic composition comprising an isolated DNA molecule encoding a plurality of viral genes consisting of a gag gene of Human Immunodeficiency Virus (HIV), a pro gene of HIV, a vpx gene of Simian Immunodeficiency Virus (SIV), a vpr gene of SIV, a vpu gene of HIV, a nef gene of HIV, a tat gene of HIV, a env gene of HIV, and a rev gene of HIV, and wherein the DNA immunogenic composition does not include a functional reverse transcriptase (rt) gene, integrase (int) gene, or viral infectivity factor (vif) gene and does not include a functional 3' Long Terminal Repeat (LTR). Further provided are said compositions comprising further a promoter sequence, a cytokine and pharmaceutically acceptable carrier. Also provided is the use of the composition for the manufacture of a medicament for treating HIV infection.
Patent NZ-546744-A (NZ)
Title: Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
Inventor: HOFFMANN HOLGER
IPC: C12P17/10
Filed: 2004-10-08
Abstract: Disclosed are the compounds of formulae (I), (II), (III), (IV) wherein the substituents are disclosed within the specification. Also disclosed is the microorganism Myxococcus virescens ST200611 (DSM 15898). Also disclosed is the use of the above microorganism to prepare the compound of formula (V).
Patent NZ-548070-A (NZ)
Title: Pyrrolotriazine compounds as kinase inhibitors
Inventor: FINK BRIAN E
IPC: C07D487/04
Filed: 2004-12-23
Abstract: Disclosed is a compound of formula (III), wherein the substituents are as defined in the specification. The compounds inhibit the tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful in the treatment of cancer
Patent NZ-548176-A (NZ)
Title: Relationship management system for a contact centre
Inventor: AVERY BRETT ANDREW
Filed: 2002-01-08
Abstract: A relationship management system for a contact centre includes a message component for receiving and sending relationship messages between parties involved in operating the contact centre and a database component for maintaining profile data on the parties. The profile data includes association data that represents associations established between the parties.
Patent NZ-549066-A (NZ)
Title: Particle containing solid surface material
Inventor: THOMPSON JENNIFER L
IPC: C08K3/00
Filed: 2005-03-21
Abstract: Disclosed is a liquid casting composition, which is a precursor to a solid surface material, comprising a liquid polymerizable component, polycarboxylic acid, or salt thereof, having at least two carboxylic acid groups and having a molecular weight in between 300 grams per mole to 50,000 grams per mole, and further comprising solid particles, which comprise first particles having a distribution in the range from 1 micron to 300 microns, and second particles having a distribution in the range from 0.1mm to 12mm.
Patent NZ-553162-A (NZ)
Title: Double stranded siRNA compounds that inhibit RRTP801
Inventor: FEINSTEIN ELENA
IPC: A61K48/00
Filed: 2005-08-16
Abstract: Disclosed is a double-stranded siRNA compound having the structure: 5 '  (N) x -Z  3'  (antisense strand) 3'  Z'-(N'}y  5'   (sense strand), wherein each N and N' is a ribonucleotide which may be modified or unmodified in its sugar residue and each of (N)x and (N')y is an oligomer in which each consecutive N or N' is joined to the next N or N' by a covalent bond; wherein each of x and y is an integer between 19 and 40; wherein each of Z and Z' may be present or absent, but if present is dTdT and is covalently attached at the 3' terminus of the strand in which it is present; and wherein the sequence of (N)" comprises a sequence set forth in any of SEQ ID Nos.: 66, 74, 75, 77, 79, and 91.
Patent NZ-556477-A (NZ)
Title: Heterocyclic aspartyl protease inhibitors
Inventor: ZHU ZHAONING
IPC: C07D407/10
Filed: 2005-06-09
Abstract: Disclosed is a compound of the formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, and pharmaceutical compositions comprising the compounds of formula (I). The compounds inhibit aspartyl protease and are useful for treating cardiovascular diseases, cognitive and neurodegenerative diseases, human immunodeficiency virus (HIV), plasmepsins, cathepsin D, protozoal enzymes and cognitive or neurodegenerative diseases.
Patent NZ-556660-A (NZ)
Title: A pallet made from composite parts having a core with higher crush strength when used on the outside
Inventor: ROTH ARTHUR J
IPC: B29C70/02
Filed: 2005-12-29
Abstract: A shipping pallet (800) is disclosed. The pallet structure comprises a plurality of stringer boards (802) or blocks and a plurality of composite upper-deck boards (804, 806) fastened to them. The upper-deck boards (804, 806) include two outside-edge boards (806) that flank a plurality of interior boards (804). Each of the upper-deck boards (804, 806) are made from a dimensionally stable core material sheathed in and bonded to a dimensionally stable laminar covering but the core material of the interior deck boards(804) has a lesser crush resistance and lower density than either of the outside edge boards (806). The laminar covering is comprised of at least one band of substantially parallel reinforcing cords bonded to at least one layer of a dimensionally stable web material selected from the group consisting of rigidified paper and rigidified cloth. Preferably the band of reinforcing cords is sandwiched between two layers of rigidified paper or cloth. The core material can be, for example, a foamed synthetic resin with or without filler. A continuous process for manufacturing the material is disclosed.
Patent NZ-562165-A (NZ)
Title: Feeder assembly for particle blast system
Inventor: RIVIR MICHAEL
IPC: B24C7/00
Filed: 2003-04-01
Abstract: A particle blast system includes a feeder assembly having a rotor with a plurality of pockets formed in the peripheral surface. The transport gas flowpath includes the pockets, such that substantially all transport gas flows through the pockets. The seal adjacent the peripheral surface is actuated by the transport gas pressure to urge its sealing surface against the rotor's peripheral surface. At start up, there is no substantial pressure between the seal and the rotor, reducing start up torque requirements.
Patent NZ-562838-A (NZ)
Title: Combinations of penflufen and an acetylcholine receptor agonist or antagonist
Inventor: SUTY-HEINZE ANNE
IPC: A01N37/22
Filed: 2006-04-15
Abstract: Disclosed is a combination of N-[2-(1,3-dimethylbutyl)phenyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, known as penflufen, and an acetylcholine receptor agonist or antagonist such as acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam, nicotine, bensultap or cartap. The combinations are useful for controlling unwanted animal pests such as insects or mites as well as unwanted phytopathogenic fungi.
Patent NZ-563759-A (NZ)
Title: Compositions comprising nebivolol, a hydralazine compound and an isosorbide nitrate
Inventor: MASON R
IPC: A61P9/00
Filed: 2005-11-16
Abstract: Disclosed is the use of a safe and therapeutically effective amount of a combination of: (i) nebivolol or a pharmaceutically acceptable salt thereof; (ii) at least one hydralazine compound (such as budralazine, cadralazine, dihydralazine, endralazine, hydralazine, pildralazine, todralazine) or a pharmaceutically acceptable salt thereof; and (iii) at least one of isosorbide dinitrate and/or isosorbide mononitrate, in the preparation of a medicament for improving NO release in a black patient. In conjunction with the above use, the medicament may further include one or more compounds selected from the group consisting of a digitalis compound, a diuretic compound, potassium, an angiotensin-converting enzyme inhibitor, a beta-adrenergic blocker, a cholesterol reducer, a calcium channel blocker, an angiotensin II receptor antagonist, and an endothelin antagonist.
Patent NZ-564365-A (NZ)
Title: Animal management system
Inventor: CORKE PETER IAN
IPC: A01K3/00
Filed: 2006-05-24
Abstract: Disclosed is a system for controlling and monitoring animals. The system includes control devices (10) that are fittable to the animals and arranged for communication with one another. Each control device includes means for determining the position of an animal relative to a second animal, means for determining the distance between the two animals, and means for determining movement of the animals relative to one another. The system also includes stimulus application devices (12) arranged for selective application of a stimulus to an animal based on the relative position, distance and/or movement of the animals.
Patent NZ-565397-A (NZ)
Title: Novel camptothecin analogue compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
Inventor: LAVIELLE GILBERT
IPC: A61K31/4745
Filed: 2006-08-04
Abstract: Disclosed herein are camptothecin compounds of formula (I), wherein the substituents are as defined within the specification, process for their preparation, intermediate compound of formula (III'), compositions comprising compounds of formula (I) and the use of said compounds in the treatment of cancer diseases.
Patent NZ-569965-A (NZ)
Title: Appliance pump
Inventor: COKER CLINTON
Filed: 2008-07-18
Abstract: A pump, for a washing appliance including a wash chamber, is disclosed. The pump comprises: a pump casing having a substantially cylindrical side wall, a bottom wall and a ceiling, where the pump casing receives water from the wash chamber. An inlet and outlet in the side wall is spaced apart circumferentially about the side wall and an inlet conduit at the inlet extends from the pump casing at an angle above the horizontal. A pump impeller is provided in the casing adjacent the bottom wall, where the pump impeller has vanes extending to the side wall. The ceiling includes a downwardly extending dividing wall section that extends radially from a central location to the side wall. The dividing wall has an inlet side adjacent the inlet and an outlet side adjacent the outlet. The ceiling incorporates a ramped surface rising around the central location between the outlet side and the inlet side of the dividing wall, where the ramped surface is higher adjacent the inlet side than the outlet side. The upper most periphery of the inlet is above or substantially flush with the ramped surface adjacent the inlet side of the dividing wall section so that when the impeller is not rotating, air inside the pump chamber will rise up the ramped surface through the inlet and up the inlet conduit.
Patent NZ-572564-A (NZ)
Title: Novel reagents for transfection of eukaryotic cells
Inventor: JESSEE JOEL
IPC: A01N37/18
Filed: 2006-05-17
Abstract: Disclosed is a complex comprising a transfection agent and a fusion agent, wherein said fusion agent comprises a hydrophobic amino acid sequence from the N-terminal domain of a Reovirus Fusion-Associated Small Transmembrane (FAST) protein, wherein said hydrophobic amino acid sequence comprises 5-30 contiguous amino acids of the N-terminal region sequence of said FAST protein and lacks amino acid sequences from the transmembrane domain of said protein, wherein said hydrophobic amino acid sequence is not myristoylated, and wherein said fusion agent further comprises a polycationic amino acid sequence that binds nucleic acid.
Patent NZ-574611-A (NZ)
Title: A device for detecting the presence of foot traffic where an audio or visual message is broadcast upon detection of foot traffic
Inventor: LYNCH GRAHAM BRUCE
IPC: G09F25/00
Filed: 2010-05-03
Abstract: A device and method for use in monitoring foot traffic about a foot traffic monitoring area is disclosed. The monitoring device includes a control unit provided with a controller configured and arranged with a sensor means to, in use, detect the presence of foot traffic and trigger broadcasting of an audio and/or visual message. The controller includes a data logging means adapted to count foot traffic for data capture purposes.